Weight Loss Injections
Semaglutide and tirzepatide are injectable medications that have gained significant attention for their effectiveness in weight loss. Initially developed to treat type 2 diabetes, these drugs have been shown to help individuals with overweight and obesity achieve substantial weight reduction.
How Semaglutide & Tirzepatide Work
Both semaglutide and tirzepatide work by affecting hormones in the digestive system and brain to promote weight loss.
Semaglutide: This drug is a GLP-1 (glucagon-like peptide-1) receptor agonist. GLP-1 is a hormone that the body releases after eating. Semaglutide mimics this hormone, which leads to several effects that support weight loss:
Reduced Appetite: It signals the brain to feel less hungry and more full.
Slower Gastric Emptying: It slows down how quickly food leaves the stomach, helping you feel full for longer.
Improved Blood Sugar Control: It stimulates insulin release and reduces glucagon, which helps manage blood sugar levels.
Tirzepatide: This drug is a dual GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 receptor agonist. By targeting both of these hormone receptors, it is believed to have a more potent effect on blood sugar control and weight loss. GIP also plays a role in insulin secretion and can enhance the effects of GLP-1.
How Much Weight Will I Lose in the first 3 Months?
In the first three months of using semaglutide (brands like Wegovy or Ozempic), people typically see a noticeable, but not yet dramatic, reduction in weight. This is because the body is still adjusting to the medication and the dosage is being slowly increased to minimize side effects.
Average Weight Loss: Clinical studies and cohort data show that patients lose an average of 5% to 6% of their initial body weight within the first 12 weeks.
Pounds: For a person starting at 200 pounds, this translates to a loss of approximately 10 to 12 pounds. Some studies have reported an average weight loss of around 15 pounds in this timeframe.
Tirzepatide (brands like Zepbound or Mounjaro) has shown slightly more pronounced results in the early stages, as it targets two different hormone receptors (GIP and GLP-1).
Average Weight Loss: In clinical trials (such as the SURMOUNT-1 trial), patients on tirzepatide lost an average of 4% to 7% of their body weight in the first three months.
Pounds: For a person starting at 200 pounds, this is a loss of approximately 8 to 14 pounds. Some reports from real-world use suggest a loss of 15 to 25 pounds within this timeframe is not uncommon, depending on the dosage and individual factors.
Effectiveness for Weight Loss
Both medications have shown impressive results in clinical trials and real-world studies, but tirzepatide may have a slight edge in efficacy.
Semaglutide (Brand Names: Wegovy, Ozempic): In clinical trials, participants using semaglutide for weight loss achieved an average weight loss of around 15% of their initial body weight.
Tirzepatide (Brand Names: Zepbound, Mounjaro): Studies have indicated that tirzepatide may lead to greater weight loss, with some participants losing up to 20% of their initial body weight.
It is important to note that these results are often achieved in combination with a reduced-calorie diet and increased physical activity.
Administration and Dosage
Both semaglutide and tirzepatide are administered as a once-weekly subcutaneous injection (under the skin) using a pre-filled pen.
Dose Escalation: To minimize gastrointestinal side effects, treatment typically begins with a low dose, which is gradually increased over several months until a maintenance dose is reached.
Injection Sites: The injection can be administered in the abdomen, thigh, or upper arm. It is recommended to rotate injection sites each week.
Aftercare Tips
- Nausea and vomiting
- Diarrhea or constipation
- Abdominal pain and discomfort
- Headaches or Fatigue
Are You Ready to Change Your Life?
Start your weight-loss journey today!
